Extracellular Vesicles in the Progression and Therapeutic Resistance of Nasopharyngeal Carcinoma
- PMID: 35565418
- PMCID: PMC9101631
- DOI: 10.3390/cancers14092289
Extracellular Vesicles in the Progression and Therapeutic Resistance of Nasopharyngeal Carcinoma
Abstract
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy largely associated with Epstein-Barr virus (EBV) infection, which is frequently reported in east and southeast Asia. Extracellular vesicles (EVs) originate from the endosome or plasma membrane, which plays a critical role in tumor pathogenesis for their character of cell-cell communication and its cargos, including proteins, RNA, and other molecules that can target recipient cells and affect their progression. To date, numerous studies have indicated that EVs have crucial significance in the progression, metastasis, and therapeutic resistance of NPC. In this review, we not only summarize the interaction of NPC cells and the tumor microenvironment (TME) through EVs, but also explain the role of EVs in radiation and drug resistance of NPC, which poses a severe threat to cancer therapy. Therefore, EVs may show great potential as biomarkers in the early diagnosis of interfered targets of NPC therapy.
Keywords: extracellular vesicles; nasopharyngeal carcinoma; therapeutic resistance; tumor microenvironment.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Epstein-Barr virus noncoding RNAs from the extracellular vesicles of nasopharyngeal carcinoma (NPC) cells promote angiogenesis via TLR3/RIG-I-mediated VCAM-1 expression.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1201-1213. doi: 10.1016/j.bbadis.2019.01.015. Epub 2019 Jan 16. Biochim Biophys Acta Mol Basis Dis. 2019. PMID: 30659926
-
LMP1-positive extracellular vesicles promote radioresistance in nasopharyngeal carcinoma cells through P38 MAPK signaling.Cancer Med. 2019 Oct;8(13):6082-6094. doi: 10.1002/cam4.2506. Epub 2019 Aug 22. Cancer Med. 2019. PMID: 31436393 Free PMC article.
-
Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts.J Exp Clin Cancer Res. 2022 Aug 20;41(1):254. doi: 10.1186/s13046-022-02456-5. J Exp Clin Cancer Res. 2022. PMID: 35986369 Free PMC article.
-
Updates on Epstein-Barr Virus (EBV)-Associated Nasopharyngeal Carcinoma: Emphasis on the Latent Gene Products of EBV.Medicina (Kaunas). 2022 Dec 20;59(1):2. doi: 10.3390/medicina59010002. Medicina (Kaunas). 2022. PMID: 36676626 Free PMC article. Review.
-
Unfolding the Complexity of Exosome-Cellular Interactions on Tumour Immunity and Their Clinical Prospects in Nasopharyngeal Carcinoma.Cancers (Basel). 2024 Feb 24;16(5):919. doi: 10.3390/cancers16050919. Cancers (Basel). 2024. PMID: 38473281 Free PMC article. Review.
Cited by
-
PTEN as a prognostic factor for radiotherapy plus immunotherapy response in nasopharyngeal carcinoma.J Nanobiotechnology. 2025 Apr 21;23(1):303. doi: 10.1186/s12951-025-03315-z. J Nanobiotechnology. 2025. PMID: 40259377 Free PMC article.
-
Application of small extracellular vesicles in the diagnosis and prognosis of nasopharyngeal carcinoma.Front Cell Dev Biol. 2023 Mar 10;11:1100941. doi: 10.3389/fcell.2023.1100941. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 36968209 Free PMC article. Review.
-
Cell-Cell Communication and Extracellular Vesicles in Cancer.Cancers (Basel). 2023 Apr 23;15(9):2419. doi: 10.3390/cancers15092419. Cancers (Basel). 2023. PMID: 37173886 Free PMC article.
-
The role of extracellular vesicles in the development of nasopharyngeal carcinoma and potential clinical applications.Cancer Med. 2023 Jul;12(13):14484-14497. doi: 10.1002/cam4.6099. Epub 2023 Jun 12. Cancer Med. 2023. PMID: 37306659 Free PMC article. Review.
-
Regulation of Extracellular Vesicle-Mediated Immune Responses against Antigen-Specific Presentation.Vaccines (Basel). 2022 Oct 10;10(10):1691. doi: 10.3390/vaccines10101691. Vaccines (Basel). 2022. PMID: 36298556 Free PMC article. Review.
References
-
- Hsu W.L., Tse K.P., Liang S., Chien Y.C., Su W.H., Yu K.J., Cheng Y.J., Tsang N.M., Hsu M.M., Chang K.P., et al. Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma. PLoS ONE. 2012;7:e42767. doi: 10.1371/journal.pone.0042767. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources